Prevalence of primary aldosteronism among hypertensive patients

被引：0
|
作者：
Fogari, R [1 ]
Preti, P [1 ]
Mugellini, A [1 ]
Rinaldi, A [1 ]
Pasotti, C [1 ]
Fogari, E [1 ]
Corradi, L [1 ]
机构：
[1] Univ Pavia, Policlin San Matteo, Med Clin 2, Dept Internal Med & Therapeut, I-27100 Pavia, Italy
来源：
JOURNAL OF HYPERTENSION | 2004年 / 22卷
关键词：
D O I：
10.1097/00004872-200402001-00885
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [21] Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects
    Ito, Yuji
    Takeda, Ryoyu
    Karashima, Shigehiro
    Yamamoto, Yasuhiro
    Yoneda, Takashi
    Takeda, Yoshiyu
    [J]. HYPERTENSION RESEARCH, 2011, 34 (01) : 98 - 102
  • [22] Prevalence of primary aldosteronism: Should we screen for primary aldosteronism before treating hypertensive patients with medication?
    Nishikawa, Tetsuo
    Saito, Jun
    Omura, Masao
    [J]. ENDOCRINE JOURNAL, 2007, 54 (04) : 487 - 495
  • [23] Prevalence of Primary Aldosteronism in Hypertensive Subjects with Hyperglycemia
    Li, Nanfang
    Wang, Menghui
    Wang, Hongmei
    Zhang, Delian
    Wang, Xinling
    Zu, Feiya
    Chang, Guijuan
    Zhou, Keming
    [J]. CLINICAL AND EXPERIMENTAL HYPERTENSION, 2013, 35 (03) : 175 - 182
  • [24] PREVALENCE OF PRIMARY ALDOSTERONISM IN AN URBAN HYPERTENSIVE POPULATION
    Galati, Sandi-Jo
    Cheesman, Khadeen C.
    Springer-Miller, Ryan
    Hopkins, Sarah M.
    Krakoff, Lawrence
    Bagiella, Emilia
    Zhuk, Rachel A.
    Ying, Tiffany K.
    Amer, Chelsey
    Boyajian, Michael K.
    Inabnet, W. B., III
    Levine, Alice C.
    [J]. ENDOCRINE PRACTICE, 2016, 22 (11) : 1296 - 1302
  • [25] Prevalence of Primary Aldosteronism in an Urban Hypertensive Population
    Galati, Sandi-Jo
    Hopkins, Sarah M.
    Cheesman, Khadeen C.
    Zhuk, Rachel A.
    Amer, Chelsey
    Boyajian, Michael K.
    Bagiella, Emilia
    Inabnet, William B.
    Levine, Alice C.
    [J]. ENDOCRINE REVIEWS, 2014, 35 (03)
  • [26] Prevalence of primary aldosteronism among patients with type 2 diabetes
    Tancredi, Mauro
    Johannsson, Gudmundur
    Eliasson, Bjorn
    Eggertsen, Robert
    Lindblad, Ulf
    Dahlqvist, Sofia
    Imberg, Henrik
    Lind, Marcus
    [J]. CLINICAL ENDOCRINOLOGY, 2017, 87 (03) : 233 - 241
  • [27] Prevalence of glucocorticoid-remediable aldosteronism among newly diagnosed patients with primary aldosteronism
    Widimsky, J., Jr.
    Lacinova, Z.
    Zelinka, T.
    Dvorakova, J.
    Zogala, D.
    Strauch, B.
    Petrak, O.
    Holaj, R.
    Seeman, T.
    Hampf, M.
    Bernhardt, R.
    [J]. JOURNAL OF HYPERTENSION, 2006, 24 : S358 - S358
  • [28] Prevalence of primary aldosteronism (PA) nationwide in Italy in newly diagnosed hypertensive patients
    Rossi, GP
    Mantero, F
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 239A - 239A
  • [29] A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients
    Rossi, Gian Paolo
    Bernini, Giampaolo
    Caliumi, Chiara
    Desideri, Giovambattista
    Fabris, Bruno
    Ferri, Claudio
    Ganzaroli, Chiara
    Giacchetti, Gilberta
    Letizia, Claudio
    Maccario, Mauro
    Mallamaci, Francesca
    Mannelli, Massimo
    Mattarello, Mee-Jung
    Moretti, Angelica
    Palumbo, Gaetana
    Parenti, Gabriele
    Porteri, Enzo
    Semplicini, Andrea
    Rizzoni, Damiano
    Rossi, Ermanno
    Boscaro, Marco
    Pessina, Achille Cesare
    Mantero, Franco
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 48 (11) : 2293 - 2300
  • [30] Efficacy of spiranolactone among resistant hypertensive patients with or without primary aldosteronism.
    Nishizaka, MK
    Zaman, MA
    Calhoun, DA
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S282 - S282
12345